Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:9253 |
Name | gastrointestinal stromal tumor |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer gastrointestinal system cancer gastrointestinal stromal tumor |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
KIT amp | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K642E | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT positive | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT act mut | Cabozantinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT act mut | Pexidartinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560D KIT D820A | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT V560D KIT D820A | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT mutant | N/A | gastrointestinal stromal tumor | not applicable | detail... |
KIT exon9 | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT T670I | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560_L576del | Ponatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_L576del | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Ponatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_L576del KIT V654A | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT T670I | Ponatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT T670I | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT D816E | Sunitinib | gastrointestinal stromal tumor | decreased response | detail... |
KIT V560_Y578del KIT A829P | Sunitinib | gastrointestinal stromal tumor | decreased response | detail... |
KIT K642E | Ponatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT N822K | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT Y823D | Ponatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557C KIT K558_V560del | Ponatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT P551_W557delinsL | Ponatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT M552_K558del | Ponatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del | Mirdametinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K642E | Imatinib + Infigratinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Imatinib + Infigratinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT mutant | Imatinib + Infigratinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT Y823D | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Ponatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 | Dasatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 | Nilotinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT P551_V555del | Sorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT P551_V555delinsTL | Sorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K558_G565delinsR | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT A502_Y503dup | Imatinib | gastrointestinal stromal tumor | conflicting | detail... |
KIT W557Lfs*5 KIT P577del KIT D820G | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT K558_G565delinsR | Cabozantinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT A502_Y503dup | Cabozantinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557Lfs*5 KIT P577del KIT D820G | Cabozantinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Imatinib + MK2206 | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 KIT A829P | Imatinib + MK2206 | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 KIT V654A | Imatinib + MK2206 | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon13 | Imatinib + MK2206 | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon17 | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT mutant | Ripretinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon 11 del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 | Imatinib + PKF118-310 | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | Imatinib + XAV939 | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560del | G007-LK + Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT Y823D | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_V559delinsF | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT V654A | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT D820V | Avapritinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT act mut | N/A | gastrointestinal stromal tumor | not applicable | detail... |
KIT Y570_L576del KIT D816E PTEN T321fs | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT Y570_L576del KIT D816E PTEN T321fs | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT Y570_L576del KIT D816E PTEN T321fs | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 KIT T670I | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon11 KIT T670I | Sunitinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 KIT T670I | Regorafenib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT A502_Y503dup KIT D820E | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT A502_Y503dup KIT D820E | Sunitinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT A502_Y503dup | Regorafenib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT Y570_L576del KIT D816E PTEN T321fs | Imatinib + LY294002 | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | PLX9486 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon17 | PLX9486 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 | Pexidartinib + PLX9486 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon17 | Pexidartinib + PLX9486 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 KIT exon17 | PLX9486 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT W557Lfs*5 KIT P577del KIT D820G | PLX9486 | gastrointestinal stromal tumor | sensitive | detail... |
KIT D820N | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT D816E KIT D820V | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V555_L576del KIT D820G KIT D820Y | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT A502_Y503dup KIT N822K | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K558_V560del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558delinsCE KIT N822K | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V559A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V569_L576del KIT V654A KIT N822K | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT Y553S KIT W557_Q575del KIT D820Y | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT mutant | Avapritinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V560_Y578del KIT V654A | AZD3229 | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT V654A | AZD3229 | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT Y823D | AZD3229 | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Olverembatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon9 | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Axitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K642E | Axitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT T670I | Axitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V559D | Axitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K642E | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V654A | Avapritinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT T670I | Avapritinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560D | Avapritinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon 11 del | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del | Midostaurin | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT T670I | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT exon 11 del KIT T670I | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT T670I | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT T670I | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT T670I | Midostaurin | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT T670I | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D816E | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D816E | Midostaurin | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D816E | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D816E | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT D816E | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D816E | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V559_G565del KIT V654A KIT A829P | Ripretinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT Y568_L576delinsCV KIT D816E KIT D820Y | Ripretinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
CDKN2A del | Palbociclib | gastrointestinal stromal tumor | no benefit | detail... |
KIT V560_L576del KIT V654A | Olverembatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557Lfs*5 KIT P577del KIT D820G | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT A502_Y503dup | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K642E KIT C809G KIT N822H | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K642E KIT N822K | AZD3229 | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT Y823D | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K642E KIT N822K | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT V654A | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT V654A | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT V654A | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560_Y578del KIT V654A | Avapritinib | gastrointestinal stromal tumor | resistant | detail... |
KIT V560_Y578del KIT V654A | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT V560_Y578del KIT V654A | Regorafenib | gastrointestinal stromal tumor | resistant | detail... |
KIT V560_Y578del | AZD3229 | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT V560_Y578del | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon9 | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon9 | Imatinib + Infigratinib | gastrointestinal stromal tumor | no benefit | detail... |
KIT exon11 | Imatinib + Infigratinib | gastrointestinal stromal tumor | no benefit | detail... |
KIT W557_K558del KIT Y823D | PLX9486 | gastrointestinal stromal tumor | sensitive | detail... |
KIT N655K | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon 11 del | Adavosertib + Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon13 | Adavosertib + Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del | Adavosertib | gastrointestinal stromal tumor | no benefit | detail... |
KIT V560_Y578del | Copanlisib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Copanlisib + Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT T670I | Copanlisib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 KIT V654A | Copanlisib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 KIT V654A | Copanlisib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V560_Y578del KIT T670I | Copanlisib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT W557_E561del | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_E561del | Imatinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_L576del KIT V654A | Imatinib | gastrointestinal stromal tumor | resistant | detail... |
KIT V560_L576del KIT V654A | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del | THE-630 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT A502_Y503dup | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT K558_V559del | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT E562_L576del | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V560D | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT E554_K558del | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT W557_K558del KIT N822K | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT Q556_I571del KIT V654A | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT Q556_V559delinsHT KIT V654A | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560D KIT D820G KIT N822K KIT Y870* | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT E562_L576del KIT N822Y | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT E554_K558del KIT V654A | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT exon9 | Regorafenib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_L576del | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V560_Y578del KIT T670I | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT V559D | Nintedanib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT K642E | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT K509I | Imatinib | gastrointestinal stromal tumor | no benefit | detail... |
KIT V560E | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT K642E | IDRX-42 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT W557Lfs*5 KIT P577del KIT D820G | IDRX-42 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT A502_Y503dup | IDRX-42 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
PIK3CA L10_P18del PIK3CA E545K | Alpelisib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon9 | Ponatinib | gastrointestinal stromal tumor | no benefit | detail... |
KIT E554_Y570del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT E554_Y570del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT W557_K558del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT T670I | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT D816H | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT Y823D | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_E561del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_E561del KIT N822D | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT M552_D572del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT M552_D572del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V560del KIT N822K | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V555_D572del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V555_D572del KIT N822K | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V555_D572del KIT N822Y | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT P551I KIT M552_V559del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT P551I KIT M552_V559del KIT Y823D | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560_D572del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V560_D572del KIT A829P | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V559_T574del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V559_T574del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K558N KIT V560del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT Y570_Y578del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT Q556_W557del | Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT Q556_W557del KIT V654A | Imatinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V560D KIT D820A | Imatinib + Infigratinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT W557Lfs*5 KIT P577del KIT D820G | Dovitinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT A502_Y503dup | Binimetinib + Dovitinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT A502_Y503dup | Dovitinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
BRAF V600E | Dabrafenib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT V560del | Binimetinib + Imatinib | gastrointestinal stromal tumor | predicted - sensitive | detail... |
BRAF V600E | Dabrafenib + Trametinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 KIT exon13 | DCC-3009 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon11 KIT exon17 | DCC-3009 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon 11 del KIT V654A | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A KIT D816A | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A KIT D820A | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A KIT N822K | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A KIT A829P | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT N822K | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D816A | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT A829P | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT C809G | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D820A | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D820Y | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT A502_Y503dup | Ripretinib | gastrointestinal stromal tumor | resistant | detail... |
KIT A502_Y503dup KIT N822K | Ripretinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT N822K | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT D816A | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT A829P | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT D820A | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT D820Y | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT A502_Y503dup | Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT A502_Y503dup KIT N822K | Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT N560_Y574del KIT V654A | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT V654A | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT M552_E554delinsK KIT V654A | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT V559_E561del KIT T670I | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT V654A KIT D820V | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K558_V559delinsN KIT T670E | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT Q556_V559delinsH KIT T670I | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT A502_Y503dup KIT T574_P577del KIT V654A KIT N822K | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K642E KIT N822Y | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K550_K558del KIT V654A KIT A829P | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT Q556_K558delinsE KIT V654A KIT Y823H | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT W557_K558del KIT V654G KIT D816H | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT K550_V555del KIT V654A KIT C809G | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT Q556_V559delinsH KIT Y823D | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT P551_E554delinsQ KIT S645_L647dup KIT D820Y | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT exon 11 del | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT A502_Y503dup | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D820A | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT T670I | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D820Y | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A KIT D820A | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A KIT A829P | Nintedanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A | Nintedanib | gastrointestinal stromal tumor | decreased response | detail... |
KIT exon 11 del KIT V654A KIT D820A | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A KIT N822K | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A KIT A829P | Avapritinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A KIT D820A | Crenolanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT V654A KIT A829P | Crenolanib | gastrointestinal stromal tumor | sensitive | detail... |
KIT W557_K558del KIT V654A KIT I748D | Ripretinib | gastrointestinal stromal tumor | predicted - resistant | detail... |
KIT exon 11 del KIT V654A KIT D816A | Ripretinib + Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A KIT D820A | Ripretinib + Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A KIT A829P | Ripretinib + Sunitinib | gastrointestinal stromal tumor | resistant | detail... |
KIT exon 11 del KIT V654A | Ripretinib + Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon 11 del KIT D820A | Ripretinib + Sunitinib | gastrointestinal stromal tumor | sensitive | detail... |
KIT exon11 | IDRX-42 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon9 | IDRX-42 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
KIT exon9 | Imatinib + Spartalizumab | gastrointestinal stromal tumor | no benefit | detail... |
KIT exon11 | Imatinib + Spartalizumab | gastrointestinal stromal tumor | no benefit | detail... |
KIT positive | NN3201 | gastrointestinal stromal tumor | predicted - sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT00290485 | Phase II | Imatinib | Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST) | Unknown status | CAN | 0 |
NCT00812240 | Phase III | Masitinib Imatinib | A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment | Terminated | USA | LBN | FRA | 0 |
NCT01396148 | Phase II | Sunitinib | A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor | Completed | USA | FRA | CZE | 0 |
NCT01643278 | Phase I | Dasatinib + Ipilimumab | Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic | Completed | USA | 0 |
NCT01738139 | Phase I | Imatinib + Ipilimumab | Ipilimumab and Imatinib Mesylate in Advanced Cancer | Completed | USA | 0 |
NCT01874665 | Phase II | Ponatinib | A Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor | Completed | USA | 0 |
NCT01991379 | Phase Ib/II | Binimetinib + Imatinib | MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | Active, not recruiting | USA | 0 |
NCT02015065 | Phase II | Vandetanib | Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors | Completed | USA | 0 |
NCT02034110 | Phase II | Dabrafenib + Trametinib | Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers | Completed | USA | SWE | NOR | NLD | ITA | FRA | ESP | DNK | DEU | CAN | BEL | AUT | 2 |
NCT02071862 | Phase I | Everolimus + Telaglenastat Erlotinib + Telaglenastat Docetaxel + Telaglenastat Telaglenastat Paclitaxel + Telaglenastat Cabozantinib + Telaglenastat | Study of the Glutaminase Inhibitor CB-839 in Solid Tumors | Completed | USA | 0 |
NCT02122809 | Phase I | Chiauranib | Phase I Study of Chiauranib in Patients With Advanced Solid Tumors | Completed | 1 | |
NCT02164240 | Phase I | Sunitinib Regorafenib | Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST | Completed | USA | 0 |
NCT02232620 | Phase II | Amcasertib | A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors | Terminated | CAN | 0 |
NCT02257541 | Phase Ib/II | Imatinib + Infigratinib | BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | Completed | USA | 0 |
NCT02260505 | Phase III | Imatinib | Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist) | Completed | FRA | 0 |
NCT02401815 | Phase Ib/II | PLX9486 + Sunitinib Pexidartinib + PLX9486 PLX9486 | PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors | Completed | USA | 0 |
NCT02406781 | Phase II | Cyclophosphamide + Pembrolizumab Cyclophosphamide + GLA-SE + Pembrolizumab | Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC) | Unknown status | FRA | 0 |
NCT02508532 | Phase I | Avapritinib | Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors | Completed | USA | POL | NLD | ITA | GBR | FRA | ESP | DEU | BEL | 1 |
NCT02574663 | Phase I | Gemcitabine + Nab-paclitaxel Bevacizumab Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab Umbralisib | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | Completed | USA | 0 |
NCT02638766 | Phase II | Regorafenib | Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI) | Completed | ITA | FRA | ESP | 0 |
NCT02847429 | Phase III | Crenolanib | Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST | Unknown status | USA | POL | NOR | ITA | FRA | ESP | DEU | 0 |
NCT02880020 | Phase II | Nivolumab Ipilimumab + Nivolumab | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery | Completed | USA | 0 |
NCT02992912 | Phase II | Atezolizumab | Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours (SABR-PDL1) | Active, not recruiting | FRA | 0 |
NCT03109301 | Phase II | Selumetinib | A Phase II Trial of the Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) | Withdrawn | 0 | |
NCT03158103 | Phase I | Binimetinib + Pexidartinib | A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | Completed | USA | 0 |
NCT03165721 | Phase II | Guadecitabine | A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer | Terminated | USA | 0 |
NCT03291054 | Phase II | Epacadostat + Pembrolizumab | Epacadostat and Pembrolizumab in Patients With GIST | Terminated | USA | 0 |
NCT03353753 | Phase III | Ripretinib | Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (invictus) | Completed | USA | POL | NLD | ITA | GBR | FRA | FIN | ESP | DEU | CAN | BEL | AUS | 1 |
NCT03411915 | Phase I | XmAb18087 | A Study of XmAb18087 in Subjects With NET and GIST | Completed | USA | 0 |
NCT03465722 | Phase III | Regorafenib Avapritinib | (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST | Completed | USA | SWE | POL | NLD | ITA | HUN | GBR | FRA | ESP | DEU | CZE | CAN | BEL | AUT | AUS | 3 |
NCT03475953 | Phase Ib/II | Avelumab + Regorafenib | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE) | Recruiting | FRA | 0 |
NCT03556384 | Phase II | Temozolomide | Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) | Active, not recruiting | USA | 0 |
NCT03673501 | Phase III | Sunitinib Ripretinib | A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue) | Active, not recruiting | USA | SWE | POL | NOR | NLD | ITA | ISR | HUN | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BEL | AUS | ARG | 4 |
NCT04000529 | Phase I | Spartalizumab + TNO155 Ribociclib + TNO155 | Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies | Terminated | USA | ESP | DEU | BEL | AUS | 4 |
NCT04138381 | Phase Ib/II | Imatinib + Selinexor | Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST) | Unknown status | ESP | 0 |
NCT04193553 | Phase II | Lenvatinib | Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure (LENVAGIST) | Completed | FRA | 0 |
NCT04276415 | Phase I | DS-6157a | DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) | Terminated | USA | 1 |
NCT04530981 | Phase I | Repaglinide + Ripretinib | A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST | Completed | USA | 0 |
NCT04595747 | Phase II | Rogaratinib | Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) | Active, not recruiting | USA | 0 |
NCT04714983 | Phase I | DNX-2440 | DNX-2440 for Resectable Colorectal Liver Metastasis | Suspended | USA | 0 |
NCT04908176 | Phase I | Avapritinib + Midazolam | A Drug-drug Interaction Study of Avapritinib and Midazolam | Completed | USA | 0 |
NCT04924075 | Phase II | Belzutifan | Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2alpha Related Genetic Alterations (MK-6482-015) | Recruiting | USA | TUR | SWE | NOR | NLD | ITA | ISR | HUN | GBR | FRA | ESP | DNK | DEU | CAN | AUS | 6 |
NCT04936178 | Phase I | NB003 | A Study of NB003 in Patients with Advanced Malignancies | Recruiting | USA | GBR | FRA | ESP | 2 |
NCT05006794 | Phase I | GS-9716 + Sacituzumab govitecan-hziy GS-9716 Docetaxel + GS-9716 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies | Recruiting | USA | ISR | 0 |
NCT05009927 | Phase II | Imatinib | Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten) | Recruiting | FRA | 0 |
NCT05080621 | Phase Ib/II | Binimetinib + Ripretinib | Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) | Withdrawn | 0 | |
NCT05152472 | Phase II | Imatinib Atezolizumab + Imatinib | A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus Imatinib Resumption Alone in Patients with Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST) | Recruiting | FRA | 0 |
NCT05160168 | Phase Ib/II | THE-630 | A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) | Terminated | USA | 0 |
NCT05208047 | Phase III | Sunitinib PLX9486 + Sunitinib PLX9486 | (Peak) a Phase 3 Randomized Trial of CGT9486+Sunitinib Vs. Sunitinib in Subjects with Gastrointestinal Stromal Tumors | Recruiting | USA | SWE | POL | NOR | NLD | ITA | HUN | GBR | FRA | ESP | DNK | DEU | CZE | CAN | BRA | AUS | ARG | 5 |
NCT05245968 | Phase I | Imatinib Sunitinib Pimitespib Imatinib + Pimitespib | A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) | Recruiting | AUS | 4 |
NCT05366816 | Phase II | Regorafenib Sunitinib | ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST | Recruiting | USA | 0 |
NCT05489237 | Phase I | IDRX-42 | A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST 1] | Recruiting | USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL | 3 |
NCT05493215 | Phase II | Imatinib | Imatinib TDM in GIST | Recruiting | USA | 0 |
NCT05734105 | Phase III | Ripretinib Sunitinib | A Study of Ripretinib Vs Sunitinib in Patients with Advanced GIST with Specific KIT Exon Mutations Who Were Previously Treated with Imatinib (INSIGHT) | Recruiting | USA | POL | NOR | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BRA | AUS | 3 |
NCT05957367 | Phase Ib/II | DCC-3116 + Ripretinib Cetuximab + DCC-3116 + Encorafenib | A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies | Recruiting | USA | 0 |
NCT06087263 | Phase II | Regorafenib | Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting. | Recruiting | USA | 0 |
NCT06208748 | Phase II | PLX9486 + Sunitinib | SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST | Recruiting | USA | 0 |
NCT06630234 | Phase Ib/II | DCC-3009 | A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) | Recruiting | USA | 0 |
NCT06805825 | Phase I | NN3201 | A Study of the C-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced And/or Metastatic Solid Tumors Known to Express C-Kit | Recruiting | USA | 0 |